Vazirani Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Vazirani Asset Management’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-350,000	Closed	-$1.06M	–	26
2024 Q4	$1.06M	Buy	350,000 +250,000	+250%	+$1.09M	3.3%	7
2024 Q3	$519K	Buy	+100,000	New	+$497K	0.92%	18

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vazirani Asset Management's RVNC Position: Q1 2025 in Review

Vazirani Asset Management sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 350,000 shares — an estimated $1.06M sold.

Vazirani Asset Management first reported a position in RVNC in Q3 2024 and held it in 2 quarters. The position peaked at $1.06M in Q4 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

Vazirani Asset Management reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
Vazirani Asset Management sold 350,000 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $1.06M.
Vazirani Asset Management first reported a position in Revance Therapeutics, Inc. in Q3 2024 and held it in 2 quarters.
Vazirani Asset Management's Revance Therapeutics, Inc. position peaked at $1.06M in Q4 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on Vazirani Asset Management's 13F filing for Q1 2025, filed 15 May 2025.